BaeHR, LeungPS, TsuneyamaK, et al.2016. Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance. Hepatology, 64(4):1189–1201.
2.
BurkeJD, YoungHA. 2019. IFN-γ: a cytokine at the right time, is in the right place. Semin Immunol, 43:101280.
3.
FenimoreJ, YoungHA. 2016. Regulation of IFN-γ expression. Adv Exp Med Biol, 941:1–19.
4.
GeorgeCX, RamaswamiG, LiJB, et al.2016. Editing of cellular self-RNAs by adenosine deaminase ADAR1 suppresses innate immune stress responses. J Biol Chem, 291(12):6158–6168.
5.
GeorgeCX, SamuelCE. 1999. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc Natl Acad Sci U S A, 96(8):4621–4626.
6.
GreenDS, YoungHA, ValenciaJC. 2017. Current prospects of type II interferon γ signaling and autoimmunity. J Biol Chem, 292(34):13925–13933.
7.
HartnerJC, WalkleyCR, LuJ, et al.2009. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol, 10(1):109–115.
8.
HodgeDL, BerthetC, CoppolaV, et al.2014. IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice. J Autoimmun, 53:33–45.
9.
IsaacsA, LindenmannJ. 1957. Virus interference. I. The interferon. Proc R Soc Lond Ser B, 147(927):258–267.
10.
LiddicoatBJ, PiskolR, ChalkAM, et al.2015. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science, 349(6252):1115–1120.
11.
LinFC, KarwanM, SalehB, et al.2014. IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation. Blood, 124(25):3699–3708.
PattersonJB, SamuelCE. 1995. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol, 15(10):5376–5388.
14.
PestalK, FunkCC, SnyderJM, et al.2015. Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development. Immunity, 43(5):933–944.
15.
PfallerCK, GeorgeCX, et al.2021. Adenosine deaminases acting on rNA (ADARs) and viral infections. Annu Rev Virol, 8(1):239–264.
16.
PfallerCK, LiZ, et al.2011. Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response. Curr Opin Immunol, 23(5):573–582.
17.
RiceGI, KasherPR, ForteGM, et al.2012. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet, 44(11):1243–1248.
18.
SamuelCE. 1993. The eIF-2α protein kinases, regulators of translation in eukaryotes from yeasts to humans. J Biol Chem, 268(11):7603–7606.
19.
SamuelCE. 2001. Antiviral actions of interferons. Clin Microbiol Rev, 14(4):778–809.
20.
SamuelCE. 2019. Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses. J Biol Chem, 294(5):1710–1720.
21.
SavanR, RavichandranS, CollinsJR, et al.2009. Structural conservation of interferon gamma among vertebreates. Cytokine Growth Factor Rev, 20(2):115–124.
22.
TothAM, LiZ, CattaneoR, et al.2009. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. J Biol Chem, 284(43):29350–29356.
23.
WardSV, GeorgeCX, WelchMJ, et al.2011. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc Natl Acad Sci U S A, 108(1):331–336.
24.
YoungHA. 2006. Unraveling the pros and cons of interferon-gamma gene regulation. Immunity, 24(5):506–507.
